Literature DB >> 6457556

Cefoperazone treatment of experimental endocarditis.

R A Snepar, J Carrizosa, W D Kobasa, D Kaye.   

Abstract

Cefoperazone (10 mg/kg) and cephalothin (20 mg/kg) administered intramuscularly every 6 h were both effective in reducing the number of Staphylococcus aureus cells in vegetations in rabbits with endocarditis. Cefoperazone produced higher peak concentrations and greater bactericidal activity in serum than did cephalothin. Cefoperazone (40 mg/kg) administered every 6 h was significantly more effective than cefamandole (40 mg/kg) administered every 6 h in reducing the number of Enterobacter aerogenes cells in vegetations. Although cefamandole produced higher peak concentrations in serum, the serum bactericidal activity was greater with cefoperazone. The half-lives in serum were 0.64 h for cefoperazone and 0.46 h for cephalothin and cefamandole.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6457556      PMCID: PMC181520          DOI: 10.1128/AAC.19.5.773

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Comparative pharmacokinetics of cefamandole, cephapirin, and cephalothin in healthy subjects and effect of repeated dosing.

Authors:  M Barza; S Melethil; S Berger; E C Ernst
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

2.  Pharmacology of cefazolin in patients with normal and abnormal renal function.

Authors:  M E Levison; S P Levison; K Ries; D Kaye
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

3.  Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens.

Authors:  D T Durack; R G Petersdorf
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

4.  A guide to use of antibiotics in patients with renal disease. A table of recommended doses and factors governing serum levels.

Authors:  C M Kunin
Journal:  Ann Intern Med       Date:  1967-07       Impact factor: 25.391

5.  Antibiotic concentrations in serum, serum bactericidal activity, and results of therapy of streptococcal endocarditis in rabbits.

Authors:  J Carrizosa; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

6.  Comparative activity and beta-lactamase stability of cefoperazone, a piperazine cephalosporin.

Authors:  H C Neu; K P Fu; N Aswapokee; P Aswapokee; K Kung
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

7.  Antibiotic synergism in enterococcal endocarditis.

Authors:  J Carrizosa; D Kaye
Journal:  J Lab Clin Med       Date:  1976-07

8.  IN VITRO AND IN VIVO LABORATORY EVALUATION OF CEPHALOGLYCIN AND CEPHALORIDINE.

Authors:  W E WICK; W S BONIECE
Journal:  Appl Microbiol       Date:  1965-03

9.  Treatment of experimental Staphylococcus aureus endocarditis: comparison of cephalothin, cefazolin, and methicillin.

Authors:  J Carrizosa; J Santoro; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

10.  Failure of single doses of cefazolin and cefamandole to penetrate experimental chronic Escherichia coli abdominal abscesses.

Authors:  D N Gerding; A J Kozak; L R Peterson; W H Hall
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

  10 in total
  3 in total

1.  Enoxacin compared with cefoperazone for the treatment of experimental Enterobacter aerogenes endocarditis.

Authors:  J A Boscia; W D Kobasa; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

2.  Aztreonam, cefoperazone, and gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis in rabbits.

Authors:  W D Kobasa; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

3.  Mezlocillin and ticarcillin alone and combined with gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis.

Authors:  M E Levison; W D Kobasa
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.